Company Name:Editas Medicine Inc.
CEO: Cynthia Collins

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Editas Medicine Inc is a genome editing company which is engaged in treating patients with genetically defined diseases by correcting disease-causing genes.


Key numbers

Market Capitalization:1434942113
Shares Outstanding: 51302900
Float: 49991547
Next Earning Date:2020-03-06
TTm EPS: -2.4705
TTm Dividend Rate:
200 days moving average:24.95
50 days moving average: 29.35
One day percent Change: -1.34



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,